Positive outcomes of Phase 1 study of KORTUC for locally advanced/recurrent breast cancer presented at ICRR

The result of the Phase 1 study for locally advanced breast cancer was presented at ICRR (International Congress of Radiation Research) in Manchester, UK, by Dr. Navita Somaiah, Consultant Clinical Oncologist at the Royal Marsden Hospital and chief investigator of the study.

Further information can be found below